Company Snapshot
- Ticker
- TFX
- Name
- TFX
- Sector
- None
- Currency
- 0
- Relative Volume
- None
- Market Cap
- 5605712640.000000
- Volume
- 572,161
- Avg Volume (3M)
- 633,818
TFX
TFX
Last update recent
126.72
-0.16
(-0.13%)
Market Cap
5605712640.000000
Dividend Yield
0.00%
1Y Return
None%
Beta
None
Price & Moving Averages
Interactive chart with SMA overlays and intraday breadth.
Profitability
- Revenue
- 3189988000.000000
- EPS
- -7.34
- Dividend / Share
- None
- Total Dividends
- $0.00
- Dividend Yield
- 1.09%
- Net Income
- -327966000.000000
- Net Margin
- -10.28%
- Payout Ratio
- -18.59%
- Qtly Growth YoY
- None
Valuation & Quality
- P/E
- -17.09
- Forward P/E
- None
- P/S
- 1.76
- P/B
- 1.47
- Beta
- None
- Debt / Equity
- 0.72
- Current Ratio
- 2.57
- Return on Equity
- -0.09%
- Return on Assets
- -0.04%
Technicals & Returns
- Distance vs 200 DMA
- 2.41%
- 200 DMA
- 123.74
- Distance vs 50 DMA
- 5.42%
- 50 DMA
- 120.21
- Return 1Y
- None%
- Return YTD
- None%
- Beta (Trailing)
- None
- Relative Volume
- None
Factor Lens
Plot valuation, momentum, or volume trends.
Seasonal Performance
Company Overview
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters Read more
- Name
- TFX
- Industry
- Medical - Instruments & Supplies
- CEO
- Mr. Liam J. Kelly
- Employees
- 14,500
- IPO Date
- 1980-03-17
- Phone
- 610 225 6800
- Address
- None
- Website
- https://www.teleflex.com
Dividend Yield
0.00%
TTM Distributions
$0.00
Last Payout
2024-08-15 • $0.34
Latest News
Curated headlines from premium sources.
Teleflex: Selling, But How Much?
Teleflex Incorporated rebounded from lows after announcing a $2.03B divestiture of Acute Care, Interventional Urology, and OEM businesses. TFX will use $1B of …
Thermo Fisher Scientific (NYSE:TMO) vs. Teleflex (NYSE:TFX) Financial Comparison
Teleflex (NYSE: TFX - Get Free Report) and Thermo Fisher Scientific (NYSE: TMO - Get Free Report) are both medical companies, but which is the better business?…
Teleflex Incorporated (TFX) Presents at Jefferies London Healthcare Conference 2025 Transcript
Teleflex Incorporated ( TFX ) Jefferies London Healthcare Conference 2025 November 18, 2025 5:00 AM EST Company Participants Liam Kelly - Chairman, President &…
Don't Overlook Teleflex (TFX) International Revenue Trends While Assessing the Stock
Explore Teleflex's (TFX) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Teleflex Incorporated (NYSE:TFX) Receives Consensus Rating of “Reduce” from Analysts
Teleflex Incorporated (NYSE: TFX - Get Free Report) has been given an average rating of "Reduce" by the twelve ratings firms that are presently covering the fi…
Teleflex Incorporated (TFX) Discusses Strategic Rationale and Portfolio Overview of Acquired Vascular Intervention Business Transcript
Teleflex Incorporated ( TFX ) Discusses Strategic Rationale and Portfolio Overview of Acquired Vascular Intervention Business November 14, 2025 8:00 AM EST Com…